Navigation Links
MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
Date:12/19/2012

SAINT PAUL, Minn., Dec. 19, 2012 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology company, today reported financial results for the fourth quarter and fiscal year 2012 ended October 31, 2012.

(Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO)

Fourth Quarter and Fiscal Year 2012 Highlights:

  • Fourth quarter revenue of $8.2 million increased 4% versus fourth quarter of fiscal 2011 and 19% on a sequential basis. Fiscal 2012 revenue was comparable to fiscal 2011 revenue;
  • Fiscal fourth quarter income from continuing operations was $5,000 or $0.00 per diluted share and income from discontinued operations was $785,000 or $0.20 per diluted share for comprehensive income of $790,000 or $0.20 per diluted share. The fiscal 2012 loss from continuing operations was $(1.06) million or $(0.28) per diluted share and income from discontinued operations was $1.06 million or $0.28 per diluted share for a net comprehensive loss of $(3,000) or $(0.00) per diluted share;
  • Fiscal 2012 recurring revenue (service and supplies revenues) totaled 40% of total revenue compared to 37% in fiscal 2011; 
  • Fiscal 2012 maintenance and service contract billings increased 6% on a year-over-year basis;
  • Strong year-end balance sheet with $9.7 million in cash and investments, $13.5 million of working capital and no long-term debt;
  • Rated #1 in all product and service categories of a September 24, 2012 User Satisfaction Survey by MD Buyline; a provider of objective, evidence-based information used in the selection, acquisition, and management of medical technology;
  • The Company sold the assets of its New Leaf business to Life Time Fitness, effective August 28, 2012 to focus on its core busines
    '/>"/>

  • SOURCE MGC Diagnostics Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. QBC Diagnostics Awarded GSA Contract
    2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
    3. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
    4. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
    5. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
    6. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
    7. Breakthrough Prostate Cancer Diagnostics
    8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
    9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
    10. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
    11. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... 2015 Research and ... of the "Global Craniomaxillofacial (CMF) Devices Market ... The global craniomaxillofacial devices market to grow at ... report covers the present and future scenario of ... calculate the market size, we use revenues generated ...
    (Date:9/3/2015)... , Sept. 3, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Wells Fargo Healthcare Conference at 8:50 a.m. ET on ... 9-10, 2015 at The Hyatt Regency, Boston ...
    (Date:9/3/2015)... Sept. 3, 2015 Research and Markets ( ... "Investigation Report on China Olmesartan Market, 2010-2019" report ... medoxomil was successfully developed by Sankyo Pharmaceuticals Co., Ltd ... olmesartan medoxomil was approved by FDA to enter the ... best- selling drug in the world after it succeeded ...
    Breaking Medicine Technology:Global Craniomaxillofacial (CMF) Devices Market 2015-2019 - Product Innovation and Cost Reduction a Key Market Trend 2HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2China Olmesartan Investigation Market Report 2010-2019 2
    ... Nov. 28, 2011 Mylan Inc. (Nasdaq: MYL ... final approval from the U.S. Food and Drug Administration (FDA) ... Injection, packaged in 250 mg and 500 mg Single-use Vials. ... Zinecard ® for Injection, a chemoprotective agent. ...
    ... Vt., Nov. 28, 2011 Tight integration of Ascension,s ... is expanding point-of-care procedures to new medical frontiers. At ... demonstrate the capability of ultrasound-sensor guidance to expedite nerve ... small organs, and fine needle aspiration. ...
    Cached Medicine Technology:Ultrasonix and Ascension Introduce New Ultrasound Guidance Products at RSNA 2011 2
    (Date:9/3/2015)... Ohio (PRWEB) , ... September 03, 2015 , ... ... ( http://www.tamarahartley.com ) announces the release of her debut book, “Stop Wasting Your ... Read a Book Day (September 6), Hartley’s guide to overcoming life’s obstacles by ...
    (Date:9/3/2015)... ... September 03, 2015 , ... For the second ... Annual Inc. 5000 list of fastest-growing private companies in America. President and ... the nation's companies have demonstrated such remarkably consistent high growth, particularly in the ...
    (Date:9/3/2015)... ... September 03, 2015 , ... According to an Oncology Nurse Advisor ... may help patients with oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated ... caused by HPV infections, which have a high rate of success in treatment and ...
    (Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes Carol ... announce the additional of Carol Wysham, MD, to their esteemed Board of Directors. ... Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson and ...
    (Date:9/3/2015)... ... September 03, 2015 , ... “We wish to ... impact the delicate life balance between work and leisure to the benefit of ... Leaptrott, CEO , A LifeMinder Plus® Emergency Care Document Set duly executed set ...
    Breaking Medicine News(10 mins):Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3
    ... ... the emerging medical travel space, announced that international medical quality authority, Dr. David Jaimovich, ... ... Satori World Medical, a leading global healthcare company specializing in the emerging medical travel ...
    ... smoke are at risk of lung cancer , THURSDAY, Dec. ... of malignancies caused by smoking, with a new study strengthening ... providing more bad news for people who haven,t managed to ... Epidemiology, Biomarkers & Prevention , a themed issue on tobacco, ...
    ... , Diabetes: A ... Hands-on Experience for All Ages , DETROIT, Dec. 3 ... seconds. On December 5, 2009, the Detroit Science Center will debut its ... that the public might have about diabetes, diabetes treatment and the role ...
    ... , HOUSTON, Dec. 3 Three US Oncology, Inc ... the Occupational Safety & Health category from the National ... Specialty, LP ; US Oncology Clinical & Research Pharmacy distribution ... have continuously received the Occupational Excellence Award from the national ...
    ... protected volunteers from virus linked to cervical cancer , WEDNESDAY, ... Cervarix protects women from infection for longer than six years, ... two types of HPV (HPV-16 and HPV-18) most commonly associated ... women, aged 15 to 25, with a normal cervical profile ...
    ... , Unfair Labor Practices, Protecting Donors, and ... Teamsters who work at American Red Cross (ARC) Blood ... protest unfair labor practices and problems with working conditions at ... the integrity of the blood supply, not to mention the ...
    Cached Medicine News:Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 3Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 4Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 2Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 3Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 4Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 2Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 4Health News:US Oncology Celebrates Consecutive Safety 2Health News:US Oncology Celebrates Consecutive Safety 3Health News:Cervarix Proves Effective Against HPV for Over 6 Years 2Health News:Philadelphia Red Cross Blood Workers Strike to Protect Donor and Blood Safety 2
    CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi...
    The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
    Steroid eluting pacemaker leads...
    VascoStim B 2/5F is a bipolar temporary pacing lead with a balloon. It can be placed easily by the resistance of the inflated balloon in the blood flow....
    Medicine Products: